Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment (Q77883189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Drazen JM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yandava CN

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Dubé L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Szczerback N

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Hippensteel R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Pillari A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Israel E

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Schork N

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Silverman ES

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Katz DA

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Drajesk J

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

168-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

Inhaled glucocorticoids for asthma

8 December 2019

cites work

1 reference

7 January 2021

Leukotrienes and Inflammation

1 reference

7 January 2021

Treatment of asthma with drugs modifying the leukotriene pathway

1 reference

7 January 2021

Antileukotrienes in the Treatment of Asthma

1 reference

7 January 2021

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

1 reference

7 January 2021

Egr-1 and Sp1 Interact Functionally with the 5-Lipoxygenase Promoter and Its Naturally Occurring Mutants

1 reference

7 January 2021

1 reference

7 January 2021

A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group

1 reference

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

7 January 2021

Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers

1 reference

7 January 2021

Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma

1 reference

7 January 2021

Neuropeptides in human airways: function and clinical implications

1 reference

7 January 2021

The role of platelet-activating factor in asthma

1 reference

7 January 2021

Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma

1 reference

7 January 2021

Roles of mast cell proteases in airways

1 reference

7 January 2021

Molecular mechanisms of genetic polymorphisms of drug metabolism

1 reference

7 January 2021

Enzymatic Deficiency in Primaquine-Sensitive Erythrocytes

1 reference

7 January 2021

Association between clozapine response and allelic variation in 5-HT2A receptor gene

1 reference

7 January 2021

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

1 reference

7 January 2021

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

7 January 2021

Identifiers

DOI

10.1038/9680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10369259%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference